NPS PHARMACEUTICALS INC's ticker is and the CUSIP is 62936P953. A total of 4 filers reported holding NPS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $6,367,000 | +34.7% | 178,000 | -2.1% | 0.10% | +31.5% |
| Q3 2014 | $4,727,000 | -14.1% | 181,800 | +9.1% | 0.07% | -14.1% |
| Q2 2014 | $5,506,000 | +243.3% | 166,600 | +210.8% | 0.08% | +214.8% |
| Q1 2014 | $1,604,000 | -68.6% | 53,600 | -68.2% | 0.03% | -64.9% |
| Q4 2013 | $5,116,000 | -6.2% | 168,500 | -1.7% | 0.08% | -26.0% |
| Q3 2013 | $5,455,000 | +1125.8% | 171,500 | +481.4% | 0.10% | +845.5% |
| Q2 2013 | $445,000 | – | 29,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pentwater Capital Management LP | 600,000 | $21,462,000 | 0.15% |
| GROUP ONE TRADING, L.P. | 178,000 | $6,367,000 | 0.10% |
| SIMPLEX TRADING, LLC | 157 | $26,000 | 0.00% |
| Citadel Advisors | 48,000 | $1,717,000 | 0.00% |